Petros Pharmaceuticals, Inc. (PTPI) DCF Valuation

Petros Pharmaceuticals, Inc. (PTPI) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Petros Pharmaceuticals, Inc. (PTPI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial prospects of Petros Pharmaceuticals, Inc. (PTPI) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and costs to determine the intrinsic value of Petros Pharmaceuticals, Inc. (PTPI) and inform your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 15.6 9.6 7.8 6.0 5.8 4.6 3.7 2.9 2.3 1.8
Revenue Growth, % 0 -38.63 -18.29 -23.29 -2.83 -20.76 -20.76 -20.76 -20.76 -20.76
EBITDA -14.0 -12.2 -1.6 -13.7 -4.2 -3.5 -2.8 -2.2 -1.8 -1.4
EBITDA, % -89.84 -127.72 -20.94 -229.06 -72.34 -76.63 -76.63 -76.63 -76.63 -76.63
Depreciation 5.3 6.8 7.0 5.7 3.4 3.2 2.5 2.0 1.6 1.3
Depreciation, % 34.13 70.64 89.38 95.39 58.66 69.64 69.64 69.64 69.64 69.64
EBIT -19.3 -19.0 -8.6 -19.4 -7.6 -4.6 -3.7 -2.9 -2.3 -1.8
EBIT, % -123.98 -198.36 -110.33 -324.46 -131 -100 -100 -100 -100 -100
Total Cash 2.1 17.1 23.8 9.4 13.3 3.8 3.0 2.4 1.9 1.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2.6 5.2 2.5 2.1 2.2
Account Receivables, % 16.72 53.9 31.43 35.22 38.23
Inventories 2.2 .8 .5 1.8 1.6 .8 .6 .5 .4 .3
Inventories, % 14.15 7.96 6.65 30.29 27.66 17.34 17.34 17.34 17.34 17.34
Accounts Payable 3.8 5.6 4.6 1.8 1.7 1.9 1.5 1.2 .9 .7
Accounts Payable, % 24.24 58.68 58.35 30.15 29.43 40.17 40.17 40.17 40.17 40.17
Capital Expenditure -.1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -0.45926 -0.04846504 0 0 -0.000017175083 -0.10155 -0.10155 -0.10155 -0.10155 -0.10155
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -18.9 -17.7 -9.0 -26.2 -7.6 -4.5 -3.6 -2.8 -2.3 -1.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -14.7 -10.3 -.1 -24.2 -4.2 .2 -.9 -.7 -.6 -.5
WACC, % 7.1 6.83 7.22 7.22 7.22 7.12 7.12 7.12 7.12 7.12
PV UFCF
SUM PV UFCF -2.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -9
Present Terminal Value -7
Enterprise Value -9
Net Debt -5
Equity Value -3
Diluted Shares Outstanding, MM 2
Equity Value Per Share -1.60

What You Will Get

  • Real PTPI Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Petros Pharmaceuticals' future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Data: Petros Pharmaceuticals’ historical financial statements and pre-filled projections.
  • Customizable Variables: Modify WACC, tax rates, revenue growth, and EBITDA margins to suit your analysis.
  • Real-Time Insights: Observe Petros Pharmaceuticals’ intrinsic value update instantly.
  • Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
  • Designed for Precision: A specialized tool for analysts, investors, and finance professionals.

How It Works

  • Step 1: Download the prebuilt Excel template with Petros Pharmaceuticals' data included.
  • Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Petros Pharmaceuticals' intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose This Calculator?

  • Accurate Data: Real Petros Pharmaceuticals financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
  • Time-Saving: Pre-built calculations eliminate the need to start from scratch.
  • Professional-Grade Tool: Designed for investors, analysts, and consultants.
  • User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.

Who Should Use Petros Pharmaceuticals, Inc. (PTPI)?

  • Investors: Gain insights into pharmaceutical investments with a comprehensive analysis tool.
  • Healthcare Analysts: Streamline your research with an easy-to-use financial model tailored for the biotech sector.
  • Consultants: Effortlessly modify the template for client reports or presentations in the healthcare industry.
  • Pharmaceutical Enthusiasts: Enhance your knowledge of drug development and market trends using real-case studies.
  • Educators and Students: Utilize it as an effective resource for learning about finance and pharmaceuticals in academic settings.

What the Template Contains

  • Pre-Filled Data: Includes Petros Pharmaceuticals’ historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Petros Pharmaceuticals’ profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.